Histogenics

HSGX NASDAQ
0.2088
-0.0302
-12.64%
交易中 15:11 06/18 EDT
开盘
0.2100
昨收
0.2390
最高
0.2190
最低
0.2048
成交量
942.23万
成交均量(3M)
1,160.56万
52周最高
3.010
52周最低
0.0800
换手率
9.96%
市值
1,975.24万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Histogenics HSGX股票价格,Histogenics股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Histogenics Corporation is a regenerative medicine company. The Company is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The Company's product candidate, NeoCart utilizes various aspects of regenerative medicine platform to develop a tissue implant intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. NeoCart is a cartilage-like implant created using a patient's own cartilage cells through a series of tissue engineering processes. The patient's cells are separated from a tissue biopsy specimen extracted from the patient and multiplied in its laboratory. The cells are then infused into its scaffold that provides structure for the developing implant. Before NeoCart is implanted in a patient, the cell- and scaffold construct undergoes a bioengineering process in the Company's Tissue Engineering Processor (TEP). The Company has operations in the United States and Israel.
展开 >

最近浏览

名称
价格
涨跌幅